Polymeric Nanoparticle Sales

Polymeric Nanoparticle Sales Market Outlook

The global polymeric nanoparticle market is anticipated to grow significantly, reaching approximately USD 8.5 billion by 2035, with a compound annual growth rate (CAGR) of around 12.5% during the forecast period from 2025 to 2035. This growth is driven by the increasing demand for advanced drug delivery systems, which leverage the unique properties of polymer nanoparticles to enhance therapeutic efficacy and reduce side effects. Furthermore, the rising prevalence of chronic diseases, coupled with the growing focus on targeted therapy and personalized medicine, is expected to further propel the market. Innovations in nanotechnology and the expanding applications of polymeric nanoparticles across various sectors, including healthcare and biotechnology, also play a crucial role in the market's expansion. Additionally, the growing investments in research and development by key industry players and academic institutions are expected to create new opportunities for market growth in the coming years.

Growth Factor of the Market

The polymeric nanoparticle market is primarily driven by the advancements in nanomaterials and the increasing demand for effective drug delivery systems. As researchers continue to explore new formulations that leverage polymeric nanoparticles for various applications, the market is witnessing a surge in the development of novel therapeutics that can overcome biological barriers and target specific cells. Additionally, the growing incidence of diseases such as cancer, diabetes, and neurological disorders is driving the demand for innovative treatment modalities, where polymeric nanoparticles can play a pivotal role in enhancing drug solubility and stability. The awareness regarding the benefits of personalized medicine is also contributing to the market growth, as polymeric nanoparticles can be tailored to meet the specific needs of patients. Moreover, the rising investments in healthcare infrastructure and increasing government support for nanotechnology research are further propelling the growth of the polymeric nanoparticle market.

Key Highlights of the Market

• Robust growth forecast with a CAGR of 12.5% from 2025 to 2035.
• Increasing applications in drug delivery, imaging, and tissue engineering.
• Significant advancements in nanotechnology contributing to innovative solutions.
• Rising prevalence of chronic diseases fueling demand for targeted therapies.
• Growing investments in healthcare infrastructure and R&D activities.

By Product Type

Polymeric Micelles:

Polymeric micelles are small colloidal aggregates formed by the self-assembly of amphiphilic block copolymers. These structures are effective in encapsulating poorly water-soluble drugs, enhancing their bioavailability and therapeutic efficacy. Due to their nanoscale size, polymeric micelles can pass through biological barriers, making them ideal for targeted drug delivery applications. Their ability to stabilize drugs and control release profiles has led to increased interest in their use for cancer therapy and other chronic conditions. As the pharmaceutical industry continues to seek solutions for challenging drug formulations, the demand for polymeric micelles is expected to grow significantly in the upcoming years.

Dendrimers:

Dendrimers are highly branched macromolecules with a uniform structure, providing unique properties conducive for drug delivery applications. Their well-defined architecture allows for the precise control of drug loading and release, making them suitable for targeted therapy. The multifunctional nature of dendrimers enables simultaneous delivery of therapeutic agents and imaging agents, which enhances diagnostic capabilities. Their biocompatibility and ease of modification with various functional groups further boost their appeal in the pharmaceutical sector. As research continues to uncover new applications for dendrimers, especially in targeted cancer therapy and gene delivery, their market segment is poised for growth.

Polymeric Nanocapsules:

Polymeric nanocapsules are spherical structures that can encapsulate a variety of therapeutic agents within a polymeric shell. The ability to protect sensitive drugs from degradation while controlling their release makes nanocapsules highly valuable in drug delivery applications. This product type is particularly advantageous for delivering poorly soluble drugs and enhancing their therapeutic profiles. The versatility of polymeric nanocapsules in accommodating different types of compounds including small molecules, proteins, and nucleic acids further enhances their market potential. Their applications extend beyond pharmaceuticals to cosmetics and food industries, which are also expected to fuel their demand.

Polymeric Nanospheres:

Polymeric nanospheres are spherical nanoparticles that offer a high surface area-to-volume ratio, making them ideal for drug delivery and therapeutic applications. These structures can be engineered to respond to specific stimuli, allowing for controlled drug release in targeted areas of the body. Nanospheres can encapsulate a broad range of therapeutic agents and provide sustained release, improving the efficacy of treatments. Their biocompatibility and the ability to modify their surface properties further enhance their appeal in the pharmaceutical sector. With continued research and development, polymeric nanospheres are expected to find applications in areas such as gene therapy, vaccine delivery, and more.

Polymeric Nanogels:

Polymeric nanogels are three-dimensional cross-linked structures that can swell and respond to environmental stimuli, such as pH or temperature changes. This unique property allows for the controlled release of drugs, making them suitable for various therapeutic applications, including cancer treatment and tissue engineering. Their high water retention capacity and biocompatibility make them ideal candidates for drug delivery systems. The ability to encapsulate large volumes of therapeutic agents while maintaining a controlled release profile has led to extensive research on polymeric nanogels, ensuring their steady growth in the market.

By Application

Drug Delivery:

The drug delivery segment is one of the primary applications for polymeric nanoparticles, as they provide a means to enhance the bioavailability and efficacy of various therapeutic agents. The ability of polymeric nanoparticles to encapsulate drugs, protect them from degradation, and facilitate controlled release has made them a focal point in the development of targeted therapies. Their use in delivering chemotherapeutic agents directly to tumor sites minimizes systemic toxicity and enhances treatment effectiveness. Additionally, advancements in formulation techniques are paving the way for novel drug delivery systems that incorporate polymeric nanoparticles, stimulating growth in this segment.

Imaging:

Polymeric nanoparticles are increasingly utilized in imaging applications, particularly in medical diagnostics such as MRI, CT, and fluorescence imaging. Their unique properties allow for the encapsulation of imaging agents, improving the contrast and resolution of images. The capability of polymeric nanoparticles to provide multifunctional platforms where imaging and therapeutic agents can be combined is driving research into their applications in diagnostic and therapeutic areas, including cancer and cardiovascular diseases. The growing need for precise imaging techniques to enhance diagnosis is expected to boost the polymeric nanoparticles used in imaging applications significantly.

Tissue Engineering:

In tissue engineering, polymeric nanoparticles are employed to deliver bioactive molecules and growth factors that promote tissue regeneration and repair. Their ability to mimic the extracellular matrix and their biocompatibility make them valuable in creating scaffolds for cell growth and differentiation. This application is particularly relevant in regenerative medicine and orthopedics, where there is a demand for effective treatments for damaged tissues and organs. As research progresses and the clinical use of tissue engineering expands, the role of polymeric nanoparticles in this domain is anticipated to grow, contributing to the overall market expansion.

Diagnostic:

The diagnostic applications of polymeric nanoparticles are becoming increasingly significant in the field of medicine. These nanoparticles can be tailored to improve the sensitivity and specificity of diagnostic tests, enhancing early detection of diseases. Their ability to encapsulate biomolecules and provide targeted delivery to specific cells or tissues is revolutionizing traditional diagnostic methods. As healthcare continues to move towards personalized medicine, the importance of advanced diagnostic tools using polymeric nanoparticles is expected to rise, fueling growth in this application segment.

Others:

The "Others" application segment captures additional uses of polymeric nanoparticles across various industries, including cosmetics, food technology, and environmental remediation. In cosmetics, polymeric nanoparticles are used for the delivery of active ingredients, enhancing the efficacy of skincare products. In food technology, they can be applied to improve nutrient delivery and shelf life. Additionally, in environmental remediation, polymeric nanoparticles are being explored for their ability to adsorb toxins and pollutants. This diverse range of applications indicates the versatility and potential market opportunities for polymeric nanoparticles beyond traditional pharmaceutical uses.

By Distribution Channel

Online Stores:

Online stores have emerged as a significant distribution channel for polymeric nanoparticles due to the growing trend of e-commerce in the pharmaceutical and biotechnology sectors. This channel offers convenience, allowing customers to access a wide range of products without geographical limitations. Additionally, online platforms often provide detailed product descriptions, customer reviews, and competitive pricing, making them an attractive option for researchers and companies seeking polymeric nanoparticles for their applications. As internet penetration increases and online purchasing becomes more prevalent, this distribution channel is expected to continue growing, further supporting market expansion.

Hospitals & Clinics:

Hospitals and clinics serve as critical distribution channels for polymeric nanoparticles, particularly in the context of their application in drug delivery and diagnostics. Healthcare providers often require immediate access to high-quality materials for research and clinical use, and polymeric nanoparticles are increasingly being incorporated into treatment regimens. The strong relationships between pharmaceutical companies and healthcare institutions facilitate the distribution of these advanced materials, ensuring that practitioners can access the latest innovations in drug delivery systems. As polymeric nanoparticles gain traction in clinical applications, their presence in hospitals and clinics is anticipated to grow substantially.

Specialty Stores:

Specialty stores that focus on advanced materials and biomedical products represent another vital distribution channel for polymeric nanoparticles. These stores cater to a niche market of researchers, scientists, and entrepreneurs looking for specialized products. The benefit of purchasing from specialty stores includes access to expert advice and guidance on product selection, enhancing the customer experience. As the demand for advanced nanomaterials and drug delivery systems increases, specialty stores are expected to expand their offerings, contributing to the overall growth of the polymeric nanoparticle market.

Others:

The "Others" distribution channel encompasses various alternative methods, including direct sales from manufacturers, collaborations between research institutions and industry players, and participation in trade shows and conferences. These methods provide opportunities for direct engagement with customers and allow for tailored solutions based on specific application needs. As the polymeric nanoparticle market continues to evolve, the diversification of distribution channels will play a crucial role in reaching a broader customer base and enhancing market penetration.

By Ingredient Type

PLGA:

Poly(lactic-co-glycolic acid) (PLGA) is a widely used biodegradable polymer in the formulation of polymeric nanoparticles due to its favorable biocompatibility and controlled degradation rates. PLGA nanoparticles are particularly popular in drug delivery applications, where they can encapsulate a wide range of therapeutic agents, including proteins, peptides, and nucleic acids. The versatility of PLGA allows for the design of nanoparticles with specific release profiles, making them ideal for a variety of therapeutic needs. As the demand for biodegradable and safe materials in pharmaceuticals continues to rise, PLGA nanoparticles are expected to maintain a strong presence in the market.

PEG:

Polyethylene glycol (PEG) is another crucial ingredient type used in the development of polymeric nanoparticles, particularly for enhancing the solubility and circulation time of therapeutic agents. PEGylation, the process of attaching PEG chains to nanoparticles, significantly improves their pharmacokinetics and reduces immunogenicity. This modification allows for prolonged drug release and increased stability, making PEG-based nanoparticles highly attractive for drug delivery applications. As the pharmaceutical industry seeks to develop more effective and patient-friendly drug formulations, the use of PEG in polymeric nanoparticles is anticipated to expand, driving market growth.

Polystyrene:

Polystyrene nanoparticles have gained popularity due to their ease of synthesis and functionalization, allowing for customized properties tailored to specific applications. These nanoparticles are used in various biomedical applications, including drug delivery, imaging, and diagnostics. The ability to modify the surface chemistry of polystyrene nanoparticles enhances their compatibility with different therapeutic agents and biological environments. Their application in research and development, along with growing interest in their use in drug delivery systems, positions polystyrene nanoparticles as a key ingredient type within the broader polymeric nanoparticle market.

Chitosan:

Chitosan, a biopolymer derived from chitin, is increasingly employed in the formulation of polymeric nanoparticles due to its biocompatibility, biodegradability, and non-toxicity. Chitosan nanoparticles exhibit favorable properties for drug delivery, including the ability to encapsulate a variety of bioactive molecules and enhance mucoadhesion. Their application in targeting the gastrointestinal tract, particularly in oral drug delivery systems, is gaining traction, especially for therapeutic agents that require protection from degradation. The growing emphasis on natural and sustainable materials in pharmaceuticals is expected to drive the demand for chitosan-based nanoparticles, contributing to the overall market growth.

Others:

The "Others" category for ingredient types includes various alternative polymers and materials used in the synthesis of polymeric nanoparticles. This encompasses a range of synthetic and natural polymers, each offering unique properties that can be tailored for specific applications. The continued exploration of innovative materials, such as polysaccharides, proteins, and synthetic biodegradable polymers, is paving the way for the development of novel nanoparticles with enhanced functionality. As research and development efforts in the field of nanotechnology progress, the exploration of diverse ingredient types will play a vital role in expanding the application scope of polymeric nanoparticles.

By Region

The North American region is currently leading the polymeric nanoparticle market, accounting for a significant share due to the strong presence of key market players, advanced healthcare infrastructure, and high investments in research and development. The increasing prevalence of chronic diseases, coupled with a growing demand for personalized medicine, is driving the adoption of innovative drug delivery systems in this region. The North American market is projected to experience a CAGR of approximately 12% during the forecast period, fueled by continuous technological advancements and increasing collaborations between academic institutions and industry stakeholders to explore novel applications for polymeric nanoparticles.

In Europe, the polymeric nanoparticle market is also poised for substantial growth, driven by the rising demand for advanced drug delivery systems and ongoing research initiatives in nanomedicine. The region is known for its strong emphasis on healthcare innovations and regulatory support for nanotechnology applications. The European market is expected to witness a CAGR of around 11.5% as various countries invest in healthcare infrastructure and research aimed at developing efficient therapeutic solutions. The increasing collaboration between research organizations, biotechnology firms, and pharmaceutical companies is anticipated to enhance the development and commercialization of polymeric nanoparticles across the region.

Opportunities

The polymeric nanoparticle market presents numerous opportunities, particularly in the realm of personalized medicine and targeted drug delivery. As the emphasis on individualized treatment regimens grows, there is an increasing need for drug delivery systems that can be tailored to meet the unique needs of patients. Polymer-based nanoparticles can be engineered to release therapeutic agents in a controlled manner, enabling precise targeting of diseased tissues while minimizing side effects. This capability aligns with the current trends in healthcare emphasizing the importance of personalized treatment strategies, positioning the polymeric nanoparticle market for significant growth. Furthermore, collaborations between pharmaceutical companies and research institutions are likely to accelerate the development of innovative formulations, enhancing the market's potential.

Additionally, the expansion of applications for polymeric nanoparticles beyond pharmaceuticals offers new avenues for growth. Industries such as cosmetics, food technology, and environmental remediation are increasingly exploring polymeric nanoparticles for various purposes, including enhanced product efficacy and safety. The ability to utilize polymeric nanoparticles in diverse applications presents an attractive opportunity for manufacturers to diversify their product offerings and tap into new markets. As awareness of the environmental impact of traditional materials grows, there is also a trend towards utilizing biodegradable and sustainable materials in various industries, further driving demand for polymeric nanoparticles.

Threats

Despite the positive outlook for the polymeric nanoparticle market, several threats could pose challenges to its growth. One significant concern is the regulatory landscape surrounding nanotechnology products. Regulatory bodies are continuously developing guidelines and standards for the evaluation of nanomaterials, and compliance can be complex and time-consuming. Manufacturers may face hurdles in navigating these regulations, leading to delays in product development and market entry. Furthermore, the potential toxicity and environmental concerns associated with certain polymeric nanoparticles might raise red flags for regulators and consumers, affecting market acceptance. Companies must stay informed about regulatory changes and invest in research to demonstrate the safety and efficacy of their products to mitigate these potential threats.

Another threat is the competition within the polymeric nanoparticle market. As the demand for these advanced materials grows, numerous companies are entering the fray, leading to increased competition and price pressures. Emerging players may struggle to differentiate their products in a crowded market, which could lead to reduced profit margins for established companies. The rapid pace of technological advancements in nanotechnology also means that companies must continually innovate to keep up with industry trends and customer demands. Failing to adapt to these changes could result in lost market share and diminished competitiveness.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• Sigma-Aldrich Corporation
• Amgen Inc.
• F. Hoffmann-La Roche AG
• BASF SE
• Evonik Industries AG
• Nantkwest, Inc.
• Abcam plc
• Nanobiotix
• Pfizer Inc.
• Johnson & Johnson
• Curis, Inc.
• Celgene Corporation
• Polymun Scientific GmbH

The competitive landscape of the polymeric nanoparticle market is characterized by the presence of both established players and new entrants, each vying to capture market share through innovation, strategic partnerships, and product differentiation. Established companies, such as Thermo Fisher Scientific and Merck KGaA, leverage their extensive research capabilities and global presence to drive growth in this market. These companies are focused on developing advanced polymeric nanoparticles that address the specific needs of various applications, including drug delivery and diagnostics. Moreover, their established relationships with healthcare providers and research institutions enhance their ability to market and distribute their products effectively.

Emerging players in the polymeric nanoparticle market are also making significant strides, often focusing on niche applications and leveraging cutting-edge technologies to create unique product offerings. Many of these companies prioritize research and development to stay ahead of the competition and introduce innovative solutions tailored to meet evolving industry demands. Collaborations between startups and academic institutions are fostering an environment of innovation, driving advancements in the field and resulting in the emergence of novel polymeric nanoparticle formulations that has the potential to disrupt traditional drug delivery methods.

Additionally, companies are increasingly engaging in mergers and acquisitions to fortify their market positions and expand their product portfolios. For instance, strategic partnerships between pharmaceutical firms and biotechnology companies are enabling the development of synergistic applications for polymeric nanoparticles, enhancing their therapeutic capabilities. By consolidating resources and expertise, these collaborations are expected to bolster the innovation pipeline, driving the market forward. As the polymeric nanoparticle market continues to evolve, the ability of companies to adapt to changing regulations, technology advancements, and customer preferences will be crucial in maintaining a competitive edge.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Abcam plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Amgen Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Merck KGaA
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Nanobiotix
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Curis, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Pfizer Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Nantkwest, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Johnson & Johnson
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Celgene Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Evonik Industries AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 F. Hoffmann-La Roche AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Polymun Scientific GmbH
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sigma-Aldrich Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Polymeric Nanoparticle Sales Market, By Application
    • 6.1.1 Drug Delivery
    • 6.1.2 Imaging
    • 6.1.3 Tissue Engineering
    • 6.1.4 Diagnostic
    • 6.1.5 Others
  • 6.2 Polymeric Nanoparticle Sales Market, By Product Type
    • 6.2.1 Polymeric Micelles
    • 6.2.2 Dendrimers
    • 6.2.3 Polymeric Nanocapsules
    • 6.2.4 Polymeric Nanospheres
    • 6.2.5 Polymeric Nanogels
  • 6.3 Polymeric Nanoparticle Sales Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Hospitals & Clinics
    • 6.3.3 Specialty Stores
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Polymeric Nanoparticle Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Polymeric Nanoparticle Sales market is categorized based on

By Product Type

• Polymeric Micelles
• Dendrimers
• Polymeric Nanocapsules
• Polymeric Nanospheres
• Polymeric Nanogels

By Application

• Drug Delivery
• Imaging
• Tissue Engineering
• Diagnostic
• Others

By Distribution Channel

• Online Stores
• Hospitals & Clinics
• Specialty Stores
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Sigma-Aldrich Corporation
• Amgen Inc.
• F. Hoffmann-La Roche AG
• BASF SE
• Evonik Industries AG
• Nantkwest, Inc.
• Abcam plc
• Nanobiotix
• Pfizer Inc.
• Johnson & Johnson
• Curis, Inc.
• Celgene Corporation
• Polymun Scientific GmbH